Dr. Stacey Clardy talks with Casey R. Vanderlip about whether the accelerated decline in episodic memory among APOE4 carriers is due to increased Aβ deposition or heightened susceptibility to Aβ-related effects. Read the related article…
Read MoreDr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at .
Read MoreDr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article…
Read MoreDr. Greg Cooper discusses with Dr. Dean Ornish how lifestyle interventions can significantly enhance cognition and function in patients, providing hope where traditional drug treatments have fallen short. Read the related article in . …
Read MoreDr. Vikram Karnik talks with Dr. Kate Wyman-Chick about distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease, the importance of early diagnosis, and the implications for clinical practice. Read the related article in ….
Read MoreDr. Greg Cooper talks with Dr. Clifford R. Jack Jr about objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research and clinical practice. Read the related article…
Read MoreDr. Gregg Day talks with Dr. Sebastian Palmqvist about the use of blood biomarkers to streamline the diagnostic workup and treatment of Alzheimer disease. Read the related article in . Disclosures can be found at .
Read MoreDr. Jeff Ratliff talks with Dr. Calum Alexander Hamilton about the importance of tracking and managing patients with MCI, especially those with Lewy body pathology. Read the related article in . Disclosures can be found at .
Read MoreDr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired…
Read More
Comentarios recientes